跳至主要内容
临床试验/NCT04160663
NCT04160663终止不适用

Arterial Stiffness and Atrial Fibrillation

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2019年10月29日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Mayo Clinic
入组人数
15
试验地点
2
主要终点
Recurrence of Atrial Fibrillation following cardioversion

研究概览

简要总结

Researchers are trying to determine whether arterial stiffness detected by ultrasound can predict outcomes in the development and recurrence of atrial fibrillation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 95 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients with persistent AF, scheduled for electrical cardioversion

排除标准

  • Unable to provide informed consent.
  • Patients with intramural thrombus or other conditions that preclude the performance of electrical cardioversion.
  • Patients with prior carotid stents.

结局指标

主要结局

Recurrence of Atrial Fibrillation following cardioversion

时间窗: 6 months

We will follow up by phone or look through medical records to record the number of subjects that have had a recurrence of Atrial Fibrillation. We are also looking if we can correlate the recurrence with arterial stiffness.

次要结局

  • Occurrence of stroke(6 months)
  • Occurrence of heart failure(6 months)
  • Occurrence of hospitalization(6 months)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hon-Chi Lee, M.D., Ph.D.

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验